Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts
Mirisklavos, A.; Mottram, P.L.; Smith, J.A.; Mason, A.; Dumble, L.J.; Clunie, G.J.; Panagiotopoulos, S.; Nayler, W.G.
Transplantation Proceedings 19(1 Part 2): 1259-1261
1987
ISSN/ISBN: 0041-1345 PMID: 3274313 Document Number: 301314
Document emailed within 1 workday
Related Documents
Hoshino, Y.; Suzuki, C.; Ohtsuki, M.; Masubuchi, Y.; Amano, Y.; Chiba, K. 1996: FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine a Transplantation Proceedings 28(2): 1060-1061Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
van Besouw, N.M.; Daane, C.R.; Vaessen, L.M.; Mochtar, B.; Balk, A.H.; Weimar, W. 1997: Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allografts Transplantation 63(9): 1313-1318
Kaufman, D.B.; Field, M.J.; Gruber, S.A.; Farney, A.C.; Stephanian, E.; Gores, P.F.; Sutherland, D.E. 1992: Extended functional survival of murine islet allografts with 15-deoxyspergualin Transplantation Proceedings 24(3): 1045-1047
Paul, L.C.; Davidoff, A.; Paul, D.W.; Benediktsson, H.; Issekutz, T.B. 1993: Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts Transplantation Proceedings 25(1 Part 1): 813-814
Orlowski, J.P.; Spees, E.K. 1993: Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months Transplantation Proceedings 25(1 Part 2): 1535
Pappalettera, M.; Pizzi, C.; Cardillo, M.; Piccolo, G.; Aniasi, A.; Lecchi, L.; Poli, F.; Sirchia, G. 1994: Factors influencing cadaver kidney graft survival in two cyclosporine periods Transplantation Proceedings 26(5): 2533-2534
Green, W.F.; Niblack, G.D.; Johnson, H.K.; Richie, R.E.; Tallent, M.B.; MacDonnell, R.; Turner, B.; Harbison, P.; Ganaway, S. 1982: Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts Transplantation Proceedings 14(2): 282-286
Oluwole, S.F.; Fawwaz, R.A.; Reemtsma, K.; Hardy, M.A. 1988: The role of suppressor T lymphocytes in the induction of specific immunologic unresponsiveness to rat cardiac allografts by donor leukocytes and cyclosporine Transplantation Proceedings 20(3 Suppl 3: 1038-1044
Graham, W.H.; Childs, J.W.; De Giorgi, L.S.; Weymouth, R.J.; Seibel, H.R.; Lower, R.R. 1970: The effect of local graft irradiation on rejection of canine cardiac allografts Journal of Thoracic and Cardiovascular Surgery 60(5): 730-736
Parikh, Y.; Toledo-Pereyra, L.H.; Finkelstein, I.; Bandlien, K.; Castellanos, J.; Mittal, V. 1987: Prolonged pancreas transplant survival following graft donor pretreatment with cyclosporine a or concanavalin a Transplantation Proceedings 19(5): 4336-4339
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Ahn, M.S.; Ha, J.; Yun, I.J.; Kim, S.; Lee, J.S.; Kim, S.; Han, J.S.; Ahn, C.; Choi, Y.; Cheong, H.I.; Kim, S.T.; Kim, S.J. 1996: To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival Transplantation Proceedings 28(3): 1316-1317
Campos, L.; Deli, B.C.; Kern, J.H.; Kim, J.I.; Naji, A.; Barker, C.F.; Markmann, J.F. 1995: Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts Transplantation Proceedings 27(1): 254-255
Goto, S.; Kim, Y.I.; Moore, T.D.; Pillay, S.P.; Kamada, N. 1993: Graft survival in rats following extended cold preservation was improved with recipient pretransplant cyclosporine therapy Transplantation Proceedings 25(5): 2906
Bishop, G.A.; Sun, J.; Johnston, B.; Sheil, A.G.; McCaughan, G.W. 1995: Comparison of immune changes in rejecting rat cardiac allografts with tolerant cardiac allografts secondary to liver grafts Transplantation Proceedings 27(3): 2161-2162
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8
Lord, R.H.; Hancock, W.W.; Colby, A.J.; Padberg, W.; Diamantstein, T.; Kupiec-Weglinski, J.W.; Tilney, N.L. 1987: Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat Transplantation Proceedings 19(1 Part 1): 354-355